Staphylococcus Aureus Bacteraemia (SAB)-Support-Study

Save

Report Abuse

Description

The main objective of this study is to investigate whether checklist-based close telephone consultation and process surveillance for S. aureus bacteraemia (SAB) can improve adherence to our in-house SAB-guidelines (prospective quality- improvement group).

In addition, the effects of telephone consultation on the clinical outcome of patients will be examined.

Study Overview

Start Date
January 22, 2024
Completion Date
April 23, 2025
Enrollment
124
Date Posted
February 8, 2024
Accepts Healthy Volunteers?
No
Gender
All

Locations

Full Address
Greifswald University Medicine
Greifswald, Germany

Eligibility

Minimum Age (years)
18
Eligibility Criteria
Inclusion Criteria:

≥ 18 years
Inpatient treatment at the University Medicine Greifswald university hospital
First diagnosis of SAB in hospital

Exclusion Criteria:

SAB already known before admission
Palliative management within 48 hrs after SAB diagnosis
Death within 48 hrs after SAB diagnosis
Hospital discharge within 48hrs after SAB diagnosis

Study Contact Info

Study Contact Name
Lena Ulm
Study Contact Email
Study Contact Phone

Contact Listings Owner Form

Staphylococcus Aureus Bacteraemia (SAB)-Support-Study 0 reviews

Write Your Review

There are no reviews yet.

Write Your Review

Your email address will not be published. Required fields are marked *

Other Details

FDA Regulated Drug?
No
FDA Regulated Device?
No
NCTid (if applicable)
NCT06249451